SCHEMBL11188554

SCHEMBL11188554

CCN(CC)c1ccc(N=O)c(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
MAPT P10636 10/20 0.44
KDM4E B2RXH2 4/20 0.44
GFER P55789 3/20 0.43
MAPK1 P28482 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
HPGD P15428 3/20 0.42
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
GAA P10253 4/20 0.42
GLA P06280 1/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 2/20 0.41
FGFR1 P11362 1/20 0.41
TERT O14746 1/20 0.41
S100B P04271 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29914670 1.00 ALDH1A1 (0.59) ALDH1A1L3MBTL1MAPTKDM4EGFER
Hydrochloric Acid SCHEMBL11766454 0.98 ALDH1A1 (0.58) ALDH1A1L3MBTL1MAPTKDM4EGFER
SCHEMBL9452505 0.85 ALDH1A1 (0.46) ALDH1A1L3MBTL1MAPTKDM4EGFER
SCHEMBL23611530 0.84 ALDH1A1 (0.43) ALDH1A1L3MBTL1MAPTKDM4EGFER
SCHEMBL11024622 0.84 ALDH1A1 (0.59) ALDH1A1L3MBTL1MAPTKDM4EGFER
SCHEMBL179136 0.84 ALDH1A1 (0.43) ALDH1A1L3MBTL1MAPTKDM4EGFER
SCHEMBL30817926 0.84 ALDH1A1 (0.43) ALDH1A1L3MBTL1MAPTKDM4EGFER
SCHEMBL29752123 0.84 ALDH1A1 (0.43) ALDH1A1L3MBTL1MAPTKDM4EGFER
SCHEMBL9527481 0.84 SLC16A3 (0.49) ALDH1A1L3MBTL1GAA
Hydrochloric Acid SCHEMBL11766385 0.83 ALDH1A1 (0.45) ALDH1A1L3MBTL1MAPTKDM4EGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12605468-B2 Oxazine-based fluorophore compounds for nerve-specific imaging OREGON HEALTH & SCIENCE UNIVERSITY (US) 2026-04-21 US disclosed
US-20240360088-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-10-31 US disclosed
EP-4367104-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING Oregon Health & Science University (US) 2024-05-15 EP disclosed
CN-117677610-A Water-soluble neuro-dyes for in vivo neural specific imaging 俄勒冈健康与科学大学 2024-03-08 CN disclosed
US-20230148317-A1 OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2023-05-11 US disclosed
US-20230148317-A1 OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2023-05-11 US disclosed
WO-2023278874-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2023-01-05 WO disclosed
EP-4093443-A1 OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING Oregon Health & Science University (US) 2022-11-30 EP disclosed
US-11492359-B2 Near-infrared nerve-sparing fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-11-08 US disclosed
CN-115279423-A Oxazine-based fluorophore compounds for neurospecific imaging 俄勒冈健康与科学大学 2022-11-01 CN disclosed
US-20210317137-A1 NEAR-INFRARED NERVE-SPARING FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-10-14 US disclosed
US-20210317137-A1 NEAR-INFRARED NERVE-SPARING FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-10-14 US disclosed
US-20210236657-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-08-05 US disclosed
US-20210236657-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-08-05 US disclosed
WO-2021150979-A1 OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-07-29 WO disclosed
WO-2021150979-A1 OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-07-29 WO disclosed
WO-2020033435-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2020-02-13 WO disclosed
WO-2020023911-A2 NEAR-INFRARED NERVE-SPARING FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2020-01-30 WO disclosed
US-4423226-A PHENOXAZINE DYE INTERMEDIATES HOECHST AKTIENGESELLSCHAFT (DE) 1983-12-27 US disclosed
US-4362873-A REACTING AN AMINONITROSO WITH AN AMINOPHENOL IN PRESENCE OF ANHYDRIDE P C U K PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1982-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492359-B2 Near-infrared nerve-sparing fluorophores NTRK1, PMP22, GAP43 ALDH1A1 813/4885L3MBTL1 2675/4885MAPT 636/4885
US-20210236657-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION PFAS, NPFFR2, NPFFR1 ALDH1A1 1305/4885L3MBTL1 3166/4885MAPT 1093/4885
US-20230148317-A1 OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING GAP43, NTRK1, CHAT ALDH1A1 1300/4885L3MBTL1 2259/4885MAPT 963/4885
US-12605468-B2 Oxazine-based fluorophore compounds for nerve-specific imaging CHRNB2, CHRNB3, CHRNB4 ALDH1A1 1339/4885L3MBTL1 683/4885MAPT 2554/4885
US-20210317137-A1 NEAR-INFRARED NERVE-SPARING FLUOROPHORES NTRK1, NGF, SMN1; SMN2 ALDH1A1 822/4885L3MBTL1 1971/4885MAPT 803/4885
US-20240360088-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING PAX8, GAP43, PAX2 ALDH1A1 1457/4885L3MBTL1 1729/4885MAPT 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.